PROCEPT BioRobotics reported an 18% increase in revenue to $98.3 million for Q3 2026, driven by growth in U.S. procedures and international sales. The company saw a 22% rise in U.S. procedures and expanded its HYDROS system installations, maintaining a 66% gross margin. Despite higher operating expenses leading to a net loss of $26.5 million, PROCEPT reaffirmed its 2026 revenue guidance of $390-$410 million and expects procedure volume growth of 25-29%. The company is also preparing to present clinical trial data in early 2027, highlighting its focus on long-term growth and profitability.
PROCEPT BioRobotics reported a 66% gross margin in its Q3 2026 financial results, with revenue rising 18% to $98.3 million. For readers following the health sector, here is Pluang's market snapshot as of Nov 05, 2026 04:11 WIB: out of 150 priced US health stocks, 108 rose and 42 fell. Notable movers include TLRY at USD 2.97 (+12.08%, 89% Sell / 11% Buy), LQDA at USD 47.20 (+11.85%, 96% Sell / 4% Buy), and RVMD at USD 217.00 (+11.72%), with typical hold times ranging from 4 to 32 days on Pluang.
The global polypropylene market is projected to grow from 102.7 million tons in 2026 to 139.2 million tons by 2032, with a CAGR of 5.14%. Growth is fueled by rising demand for lightweight automotive parts, mono-material flexible packaging, and high-m...
At the 2026 Chery International User Summit, Chery Auto showcased its new physical AI technology built on decades of automotive safety data and engineering. Their CheryMind AI model and CHERY All-World Engine support autonomous robots, robotaxis, and...
NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
Sandisk Corporation is rated as a Strong Buy with a revised price target of $3,356, reflecting its deep undervaluation in the market. Despite strong Q1 2027 results, the company trades at a very low forward PEG ratio of 0.12x. The analyst estimates a...
